FDA Inspection 1111291 — Novartis Pharmaceuticals S.R.L.
The FDA completed an inspection of Novartis Pharmaceuticals S.R.L. on November 2, 2018 in Targu Mures. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 2, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Targu Mures (Romania)
Additional Details
Mutual Recognition Agreement (MRA)